CLINUVEL FY2026 Revenue Dips 1% To $94.0M From $95.0M, Cash Reserves Rise 12% To $252.1M Amid US Expansion Push
"CLINUVEL’s cash reserves following a decade of profitable operations give us financial independence in a period that has been challenging for many life science companies," said Mr Peter Vaughan, CLINUVEL’s
